secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001104659-26-038888
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences appoints Peter Anastasiou as COO; adds Troy Ignelzi to Board
--------------------------------------------------------------------------------

- Peter Anastasiou named SEVP and COO, effective April 2, 2026; resigns from Board.
- Troy Ignelzi appointed Class III director, filling vacancy; will serve on Audit and Compensation Committees.
- Antonio Gracias will not stand for re-election at 2026 annual meeting; term ends May 14, 2026.
- Geno J. Germano nominated for election to Board at 2026 annual meeting.
- Anastasiou receives $600K base salary, 55% bonus target, $3.7M option award with 4-year vest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/0001104659-26-038888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/hrmy-20260331x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-038888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer